Exchange: BATS·Updated 07:58 PM EDT
News
all
press releases
Moderna Is Now S&P 500’s No. 2 Stock This Year — Wall Street, Jim Cramer And Elon Musk Cheer Cancer Vaccine Breakthrough
The breakthrough sparked a broad biotech rally, lifting Merck, BioNTech, Arcturus, cancer-treatment developers, gene-editing stocks and biotech ETFs.
Stocktwits
More News
ATAI Stock Slips After Blockbuster Week: Cathie Wood Calls $3.8B Lilly Deal ‘Well-Deserved’ Return For Shareholders
ARKG sold 1.12 million ATAI shares last week but still held 3.19 million shares as of Friday.
Stocktwits
CMPS Stock Clocks Muted Gains But Analysts Back Psychedelic Drug’s Durability Ahead Of FDA Filing
Multiple analysts reiterated optimism on CMPS stock after the company announced 26-week data from its second late-stage trial of COMP360 in treatment-resistant depression.
Stocktwits
Best ETF Areas of June
Biotech, China, insurance and healthcare ETFs led June gains as strong earnings, AI optimism and easing geopolitical fears lifted markets.
Zacks
ABSI Stock Eyes Best Day Ever After Positive Hair Loss Drug Data, $100M Lilly-Backed Raise
Absci Corporation said that its drug ABS-201 was well-tolerated and showed a long-lasting presence in the body in a clinical trial.
Stocktwits
Biotech ETFs Put Up Strong Show in 1H 2026: More Gains Ahead?
Biotech ETFs are surging in 2026 as a friendlier FDA, strong M&A activity and AI-driven drug discovery fuel optimism for more upside.
Zacks
Cathie Wood's ARK Bets Bigger On This Biotech Play, Slashes Stake In This Space Stock
ARK Investment Management bought shares worth more than $3.5 million of Intellia Therapeutics and sold shares of Rocket Lab worth more than $4 million on Monday.
Stocktwits
CMPS On Track For Best Week Ever On FDA Push For Psychedelics
Compass said on Friday that the FDA has granted its synthetic psilocybin formulation the Commissioner's National Priority Voucher for treatment-resistant depression.
Stocktwits
Tempus AI Stock Near 1-Year Low: Cathie Wood’s ARK Buys More While Offloading Nvidia, Meta, Other Tech Plays
Tempus AI was the only stock purchased by ARK Innovation ETF (ARKK) in the latest session, signaling targeted conviction.
Stocktwits
Why Is CRSP Stock Falling Pre-Market Today?
The company plans to issue $350 million in convertible senior notes that are scheduled to mature in 2031.
Stocktwits

Advertisement|Remove ads.